New hope for aggressive breast cancer: personalized therapy aims for cure
NCT ID NCT02810743
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 18 times
Summary
This phase III trial tests whether a personalized, high-dose chemotherapy followed by stem cell rescue can improve cure rates for people with high-risk, BRCA1-like breast cancer. The study includes 174 participants with stage III, HER2-negative tumors. The goal is to see if this intensive approach leads to longer survival compared to standard chemotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZVU
Amsterdam, 1081 HV, Netherlands
-
Antoni van Leeuwenhoek
Amsterdam, 1066 CX, Netherlands
-
Erasmus Medical Center Cancer Institute
Rotterdam, 3015CE, Netherlands
-
Hopital Tenon, University Marie-Curie
Paris, France
-
Institut Paoli Calmettes
Marseille, 13009, France
-
LUMC
Leiden, 2333 ZA, Netherlands
-
Maastricht University Medical Center
Maastricht, Netherlands
-
Medical spectrum Twente
Enschede, Overijssel, 7500 KA, Netherlands
-
Radboud UMC
Nijmegen, 6225GA, Netherlands
-
University Medical Center Groningen
Groningen, Netherlands
-
University Medical Center Utrecht
Utrecht, 3584CX, Netherlands
Conditions
Explore the condition pages connected to this study.